Document is current
Any future updates will be listed below
-
Authors
Nepal, Sushil https://orcid.org/0000-0003-4047-342X
Shah, Shyam https://orcid.org/0000-0003-1072-1824
Dhakal, Narayan Prasad
Tripathee, Umanga
Adhikari, Santusta https://orcid.org/0009-0009-4424-0165
Shrestha, Sunil https://orcid.org/0000-0002-9174-7120
Trap, Birna https://orcid.org/0000-0001-9432-9699
Hafner, Tamara https://orcid.org/0000-0002-4710-0979
Stergachis, Andy https://orcid.org/0000-0003-0057-6627
- License Information
-
More Information
Article History
Received: 22 March 2025
Accepted: 13 May 2026
First Online: 20 May 2026
Declarations
:
: The study did not involve or use human subjects or identifiable personal data, human tissue, or animals. The study involved the secondary data analysis without any personally identifiable information obtained from the VigiFlow System after being forwarded to the Uppsala Monitoring Center. This study was implemented with the permission of and in collaboration with the Department of Drug Administration, Ministry of Health and Population and Nepal Health Research Council. All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript. Ethical approval for this study from the Ethical Review Board of Nepal (approval number: 526_2022 P and 618_2024).
: We declare that the article is original, has not already been published in a journal, and is not currently under consideration by another journal. Consent for publication from the Department of Drug Administration, Ministry of Health and Population has been obtained.
: The authors declare no competing interests.
